Jemila Houacine
Research Subjects
Jemila Houacine has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Anne-Sophie Chrétien
Immunomonitoring Platform, Cancer Research Center of Marseille, CRCM, INSERM U1068, CNRS UMR7258, Aix-Marseille University U105, Marseille, France
32 shared publications - Arnaud Foussat
Alderaan Biotechnology, Paris, France
32 shared publications - Aude Le Roy
Alderaan Biotechnology, Paris, France
32 shared publications - Daniel Olive
Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille University UM105 and Paoli-Calmettes Institute, Marseille, France
32 shared publications - Laurent Gorvel
Immunity and Cancer Team, Cancer Research Center of Marseille, CRCM, INSERM U1068, CNRS UMR7258, Aix-Marseille University U105, Marseille, France
32 shared publications - Lucie Robert
Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM105, Marseille, France
32 shared publications
Latest Publications
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S3 from CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
CDC_monocyte_macrophage subpopulations gene features, related to Figure 1
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
CDC_monocyte_macrophage subpopulations gene features, related to Figure 1
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S7 from CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Percentage of immune cell types in primary TNBC, related to Figure 2
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S7 from CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Percentage of immune cell types in primary TNBC, related to Figure 2
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S6 from CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Mass cytometry panels, related to Figure 1
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S6 from CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Mass cytometry panels, related to Figure 1
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary_Materials_and_Methods_Figures_and_Figure_legends from CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Supplementary_Materials_and_Methods_Figures_and_Figure_legends
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary_Materials_and_Methods_Figures_and_Figure_legends from CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Supplementary_Materials_and_Methods_Figures_and_Figure_legends
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S2 from CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
T cell and NK cell subpopulations gene features, related to Figure 1
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
T cell and NK cell subpopulations gene features, related to Figure 1
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S1 from CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Clinical characteristics of patients with breast cancer
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Clinical characteristics of patients with breast cancer
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S4 from CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Inferred pseudotime gene features, related to Figure 1
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4 from CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Inferred pseudotime gene features, related to Figure 1
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S8 from CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Differentially expressed genes between pre-αPD-1 Tregs versus post-αPD-1 Tregs, related to Figure 4
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S8 from CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Differentially expressed genes between pre-αPD-1 Tregs versus post-αPD-1 Tregs, related to Figure 4
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
File_S1 from CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFile_S1 from CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S5 from CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Differentially expressed genes between intratumoral TNFRSF9+ eTregs versus TNFRSF9- eTregs, related to Figure 1
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S5 from CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Differentially expressed genes between intratumoral TNFRSF9+ eTregs versus TNFRSF9- eTregs, related to Figure 1